ArticleFrontiers in public health2025
Deprioritized and disrupted: tuberculosis care in the shadow of COVID-19.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Routine Molecular Surveillance of Drug-Resistant Tuberculosis: Translating Mutation Proxies into Clinical Governance Intelligence in Rural Eastern Cape.Healthcare (Basel, Switzerland) · 2026Article
- A three-phase epidemiological fluctuation framework of extrapulmonary tuberculosis in Fuyang, China: a retrospective study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic significantly disrupted tuberculosis (TB) care worldwide, undermining years of progress in TB prevention and control. This Perspective offers a comparative analysis of how TB services were affected in a high-income, low-burden country (Canada) versus two low- and middle-income, high-burden countries (India and Nigeria). Drawing on secondary data and global surveillance reports, the article highlights key disruptions across the TB care cascade, including delays in diagnosis, reduced case detection, and the collapse of community-based treatment models like DOTS. In Canada, digital transitions partially mitigated the impact, though access was unequal. In contrast, India and Nigeria faced widespread diagnostic interruptions, compounded by preexisting infrastructure gaps and limited digital access. The comparison reveals how underlying health system strength and digital readiness shaped national responses and recovery trajectories. Crucially, the pandemic exposed policy inertia and the deprioritization of routine infectious disease care in crisis contexts. This article calls for a global rethink of public health preparedness that centers on equity, continuity of essential services, and support for high burden settings. By analyzing divergent country experiences, this Perspective contributes actionable insights for strengthening TB programs and public health systems during future pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.